73579000: Carbidopa (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Substance with enzyme inhibitor mechanism of action\Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action\Carbidopa
\Substance categorized by disposition\Substance with receptor agonist mechanism of action (substance)\Substance with dopamine receptor agonist mechanism of action\Dihydroxyphenylalanine\Carbidopa

\Drug or medicament\Central nervous system agent\Antiparkinsonian agent\...

\Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action\Carbidopa

\Dihydroxyphenylalanine\Carbidopa

\Substance categorized by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Carbidopa

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Carbidopa

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

122178011 Carbidopa en Synonym Active Entire term case insensitive SNOMED CT core module

122179015 MK-486 en Synonym Active Entire term case sensitive SNOMED CT core module

813982014 Carbidopa (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3736797013 Alpha-methyldopa hydrazine en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carbidopa	Is a	Co-careldopa	false	Inferred relationship	Existential restriction modifier
Carbidopa	Is a	Antiparkinsonian agent	false	Inferred relationship	Existential restriction modifier
Carbidopa	Is a	Co-careldopa	false	Inferred relationship	Existential restriction modifier
Carbidopa	Is a	Dihydroxyphenylalanine	true	Inferred relationship	Existential restriction modifier
Carbidopa	Is a	Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action	true	Inferred relationship	Existential restriction modifier
Carbidopa	Has disposition	Dopamine receptor agonist	true	Inferred relationship	Existential restriction modifier
Carbidopa	Has disposition	Dihydroxyphenylalanine decarboxylase inhibitor	true	Inferred relationship	Existential restriction modifier
Carbidopa	Is a	Chemical categorized functionally	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier	3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has precise active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier	3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet	Has precise active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier	3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet	Has basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier	3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet	Has precise active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier	3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet	Has basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier	3
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 50mg/12.5mg/200mg tablets (DE Pharmaceuticals) 30 tablet	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (DE Pharmaceuticals) 30 tablet	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Ethigen Ltd) 100 tablet	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Ethigen Ltd)	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablet - product	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 50mg/200mg m/r tablet - product	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg m/r tablet - product	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablet - product	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 10mg/100mg tablet - product	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg tablet - product	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Half-Sinemet CR m/r tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet CR m/r tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet-62.5 tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet-110 tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet-275 tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet-Plus tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Mawdsley-Brooks & Company Ltd) 100 tablet	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Carbidopa monohydrate	Is a	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Pilsco Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (Ethigen Ltd) 100 tablet	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Pilsco Ltd) 100 tablet	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Pilsco Ltd) 50 tablet	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (Ethigen Ltd)	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (DE Pharmaceuticals) 100 tablet	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (DE Pharmaceuticals) 90 tablet	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg tablets (DE Pharmaceuticals) 90 tablet	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (DE Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (DE Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Generic Stalevo 50mg/12.5mg/200mg tablets	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Generic Stalevo 100mg/25mg/200mg tablets	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Generic Stalevo 150mg/37.5mg/200mg tablets	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 25 milligram/1 each conventional release oral tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (CST Pharma Ltd) 60 tablet	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (CST Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd)	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (CST Pharma Ltd)	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (CST Pharma Ltd) 30 tablet	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (CST Pharma Ltd)	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (CST Pharma Ltd) 30 tablet	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet	Has specific active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 10mg/100mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 10mg/100mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Kent Pharma (UK) Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Unichem Plc)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Kent Pharma (UK) Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (A A H Pharmaceuticals Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (Organon Pharma (UK) Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Approved Prescription Services)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet 12.5mg/50mg tablets (Organon Pharma (UK) Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd)	Has active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Unichem Plc)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Kent Pharma (UK) Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Unichem Plc)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 10mg/100mg tablets (A A H Pharmaceuticals Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg tablets (A A H Pharmaceuticals Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Approved Prescription Services)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet 10mg/100mg tablets (Organon Pharma (UK) Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Approved Prescription Services)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Organon Pharma (UK) Ltd)	Has active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 50mg/12.5mg/200mg tablets (Orion Pharma (UK) Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Orion Pharma (UK) Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Stalevo 150mg/37.5mg/200mg tablets (Orion Pharma (UK) Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (PI) (Waymade Ltd)	Has active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (PI) (Waymade Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet 110 tablets (PI) (Waymade Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Waymade Ltd)	Has active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/250mg tablets (PI) (Dowelhurst Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg tablets (PI) (Dowelhurst Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet 275 tablets (PI) (Dowelhurst Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Dowelhurst Ltd)	Has active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (PI) (Dowelhurst Ltd)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Tilolec 200mg/50mg modified-release tablets (Tillomed Laboratories)	Has active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Tilolec 100mg/25mg modified-release tablets (Tillomed Laboratories)	Has active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc)	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (PI) (Dowelhurst Ltd)	Has active ingredient	True	Carbidopa	Inferred relationship	Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets 100 tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet Plus 25mg/100mg tablets (PI) (Dowelhurst Ltd) 90 tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Dowelhurst Ltd) 60 tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (PI) (Dowelhurst Ltd) 100 tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Waymade Ltd) 60 tablet	Has active ingredient	False	Carbidopa	Inferred relationship	Existential restriction modifier

Start Page 2 of 13 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
122178011	Carbidopa	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
122179015	MK-486	en	Synonym	Active	Entire term case sensitive	SNOMED CT core module
813982014	Carbidopa (substance)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3736797013	Alpha-methyldopa hydrazine	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module